These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1704297)

  • 1. Increased CD5-positive B lymphocytes in type I diabetes.
    Muñoz A; Gallart T; Viñas O; Gomis R
    Clin Exp Immunol; 1991 Feb; 83(2):304-8. PubMed ID: 1704297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-islet cell and anti-insulin antibody production by CD5+ and CD5- B lymphocytes in IDDM.
    Muñoz A; Gallart T; Usac EF; Fernández-Alvarez J; Viñas O; Somoza N; Barceló J; Gomis R
    Diabetologia; 1995 Jan; 38(1):62-72. PubMed ID: 7538087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced percentage of CD5+ B lymphocytes in newly diagnosed IDDM patients.
    Nicoletti F; Meroni PL; Barcellini W; Steinsväg PO; Di Mauro M; Lunetta M; Pagano M; Consoli U; Zanussi C
    Immunol Lett; 1990 Jan; 23(3):211-5. PubMed ID: 1689697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD5+ B lymphocytes in high-risk islet cell antibody-positive and newly diagnosed IDDM subjects.
    Schatz DA; Lang F; Cantor AB; Riley WJ; Maclaren NK; Sleasman JW; Barrett DJ
    Diabetes; 1991 Oct; 40(10):1314-8. PubMed ID: 1718800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD5-positive B cells in type 1 (insulin-dependent) diabetic children.
    Lorini R; Massa M; d'Annunzio G; Cortona L; De Benedetti F; Martini A; Severi F
    Diabetes Res Clin Pract; 1993 Jan; 19(1):17-22. PubMed ID: 7682495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between circulating CD5+ B lymphocytes and in vitro autoantibody synthesis in normal individuals.
    Jasin HE
    Cell Immunol; 1991 Aug; 136(1):133-41. PubMed ID: 1711929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between CD5+ B lymphocytes and the activity of systemic autoimmunity.
    Becker H; Weber C; Storch S; Federlin K
    Clin Immunol Immunopathol; 1990 Aug; 56(2):219-25. PubMed ID: 1696188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD5+ B-cells at the onset of type I diabetes and in the prediabetic period.
    Smerdon RA; Peakman M; Hussain MJ; Wong FS; Watkins PJ; Leslie RD; Vergani D
    Diabetes Care; 1994 Jul; 17(7):657-64. PubMed ID: 7523048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in peripheral blood CD5 (Bla) B-cell populations and autoantibodies following blood transfusion.
    Paglieroni TG; Ward J; Holland PV
    Transfusion; 1995 Mar; 35(3):189-98. PubMed ID: 7533341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The frequency of CD5+ B lymphocytes in the peripheral blood of patients with myasthenia gravis.
    Ragheb S; Lisak RP
    Neurology; 1990 Jul; 40(7):1120-4. PubMed ID: 1694020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B cells expressing CD5 antigen are markedly increased in peripheral blood and spleen lymphocytes from patients with immune thrombocytopenic purpura.
    Mizutani H; Furubayashi T; Kashiwagi H; Honda S; Take H; Kurata Y; Yonezawa T; Tarui S
    Br J Haematol; 1991 Aug; 78(4):474-9. PubMed ID: 1716955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased CD5+CD19+ B lymphocytes at the onset of type 1 diabetes in children.
    De Filippo G; Pozzi N; Cosentini E; Cavalcanti M; Carel JC; Tamasi S; Franzese A; Pignata C
    Acta Diabetol; 1997 Dec; 34(4):271-4. PubMed ID: 9451471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD5 positive B lymphocytes in schizophrenia: no alteration in numbers or percentage as compared with control subjects.
    Ganguli R; Rabin BS
    Psychiatry Res; 1993 Jul; 48(1):69-78. PubMed ID: 7692460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia.
    Sthoeger ZM; Wakai M; Tse DB; Vinciguerra VP; Allen SL; Budman DR; Lichtman SM; Schulman P; Weiselberg LR; Chiorazzi N
    J Exp Med; 1989 Jan; 169(1):255-68. PubMed ID: 2462608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD5+ B cells and naturally occurring autoantibodies in cancer patients.
    Stein R; Witz IP; Ovadia J; Goldenberg DM; Yron I
    Clin Exp Immunol; 1991 Sep; 85(3):418-23. PubMed ID: 1716541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of CD5-positive B cells in nonorgan-specific autoimmune diseases.
    Youinou P; Mackenzie L; Broker BM; Isenberg DI; Drogou-Lelong A; Gentric A; Lydyard PM
    Scand J Rheumatol Suppl; 1988; 76():243-9. PubMed ID: 2471999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-affinity antibodies to ssDNA are produced by CD-B cells in systemic lupus erythematosus patients.
    Casali P; Burastero SE; Balow JE; Notkins AL
    J Immunol; 1989 Dec; 143(11):3476-83. PubMed ID: 2479680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD5 positivity on peripheral blood B lymphocytes in patients with primary Sjögren's syndrome.
    Zeher M; Surányi P; Szegedi G
    Allergol Immunopathol (Madr); 1990; 18(2):75-8. PubMed ID: 1695475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-DNA antibody production by CD5+ and CD5- B cells of patients with systemic lupus erythematosus.
    Suzuki N; Sakane T; Engleman EG
    J Clin Invest; 1990 Jan; 85(1):238-47. PubMed ID: 1688569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD5+ B lymphocytes in HIV infection: relationship to immunological progression of disease.
    Sampalo A; López-Gómez M; Jiménez-Alonso J; Ortiz F; Samaniego F; Garrido F
    Clin Immunol Immunopathol; 1993 Mar; 66(3):260-8. PubMed ID: 7679344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.